These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 30173954)
21. Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B. Kim SE Korean J Intern Med; 2017 Jul; 32(4):631-633. PubMed ID: 28704912 [No Abstract] [Full Text] [Related]
22. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study. Zhu S; Zhang H; Dong Y; Wang L; Xu Z; Liu W; Gan Y; Tang H; Chen D; Wang F; Zhao P J Hepatol; 2018 Jun; 68(6):1123-1128. PubMed ID: 29452204 [TBL] [Abstract][Full Text] [Related]
23. [Antiviral treatment of HBeAg positive chronic hepatitis B]. Wang GQ Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):540. PubMed ID: 16042897 [No Abstract] [Full Text] [Related]
24. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children. Rouet F; Chaix ML; Inwoley A; Anaky MF; Fassinou P; Kpozehouen A; Rouzioux C; Blanche S; Msellati P; Clin Infect Dis; 2008 Feb; 46(3):361-6. PubMed ID: 18171303 [TBL] [Abstract][Full Text] [Related]
25. Management of chronic hepatitis B infection. Davison S Arch Dis Child; 2014 Nov; 99(11):1037-42. PubMed ID: 24812303 [TBL] [Abstract][Full Text] [Related]
26. Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C? Song BC; Cho YK; Jwa H; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU Clin Mol Hepatol; 2014 Dec; 20(4):355-60. PubMed ID: 25548741 [TBL] [Abstract][Full Text] [Related]
27. Need to strictly define hepatitis B virus immunotolerant patients to avoid unnecessary liver biopsy. Andreani T; Serfaty L; Poupon R; Chazouilleres O Gastroenterology; 2008 Dec; 135(6):2155-6. PubMed ID: 19000682 [No Abstract] [Full Text] [Related]
32. [Long-term history of chronic hepatitis B virus infection in children]. Fujisawa T; Inui A; Sogo T; Komatsu H Nihon Rinsho; 2004 Aug; 62 Suppl 8():303-8. PubMed ID: 15453335 [No Abstract] [Full Text] [Related]
33. Update of chronic hepatitis B. Yuan H; Lee WM Curr Opin Gastroenterol; 2011 May; 27(3):217-23. PubMed ID: 21423004 [TBL] [Abstract][Full Text] [Related]
34. Posttreatment Hepatitis B Surface Antigen Seroreversion: The Bane of Combination Therapy in Chronic Hepatitis B? Sonneveld MJ; Brouwer WP; van der Meer AJ Gastroenterology; 2016 May; 150(5):1254-1255. PubMed ID: 27020333 [No Abstract] [Full Text] [Related]
35. Oral antivirals for chronic hepatitis B. Min AD; Dienstag JL Clin Liver Dis; 2007 Nov; 11(4):851-68, ix. PubMed ID: 17981232 [TBL] [Abstract][Full Text] [Related]
36. [Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis]. Wang FS; Zhang JY Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):164-6. PubMed ID: 19554778 [No Abstract] [Full Text] [Related]
37. Treatment of hepatitis B virus in children: why, whom, how? Mieli-Vergani G; Vergani D Indian J Gastroenterol; 2006; 25(3):121-4. PubMed ID: 16877822 [No Abstract] [Full Text] [Related]
38. Challenges in therapy of chronic hepatitis B. Hoofnagle JH J Hepatol; 2003; 39 Suppl 1():S230-5. PubMed ID: 14708709 [No Abstract] [Full Text] [Related]
39. Hepatitis B virus serology to predict antiviral response in chronic hepatitis B. Kim BK; Han KH; Ahn SH Digestion; 2011; 84 Suppl 1():29-34. PubMed ID: 22156483 [TBL] [Abstract][Full Text] [Related]
40. Chronic hepatitis B--new goals, new treatment. Lai CL; Yuen MF N Engl J Med; 2008 Dec; 359(23):2488-91. PubMed ID: 19052131 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]